Clinical Trials Browser

Phase 2/3 × OTHER × Lenalidomide × Clear all

NCT03759093 2023-09-06

CURATE.AI Optimized Modulation for Multiple Myeloma

Phase 2/3 Unknown

Multiple Myeloma

NCT02145598 2019-01-16

GERMAIN

Phase 2/3 Terminated

Multiple Myeloma

NCT02419118 2017-11-07

DARA

Phase 2/3 Completed

Multiple Myeloma, Neoplasms, Plasma Cell